|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 401 Ninth Street NW, Suite 900 |
Address2 |
|
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 27057-12
|
||||||||
|
6. House ID# 302500000
|
TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Beth Feldpush |
Date | 4/18/2024 11:47:07 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R.2665, Supporting Safety Net Hospitals Act
H.R.2389, the Resident Physician Shortage Reduction Act of 2023
H.R.3561 - PATIENT Act of 2023
H.R. 3887, the Childrens Hospital GME Support Reauthorization Act of 2023
H.R. 3561, PATIENT Act of 2023
H.R. 5378, The Lower Costs, More Transparency Act
S. 2719 Directing our Countrys Transfer of Residency Slots (DOCTORS) Act of 2023
S. 3196 - Ensuring Medicaid Continuity for Children in Foster Care Act
H.R. 2829 Chronic Care Management Improvement Act of 2023
H.R. 7397 -Reinforcing Essential Health Systems for Communities Act
Issues related to Section 203 of the Consolidated Appropriations Act of 2021
Issues related to the Medicare/Medicaid dual eligible population
Issues related to Medicare Site-neutral payment cuts
Issues related to Medicaid DSH Cuts
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jason |
Pray |
|
|
|
Daniel |
Jones |
|
|
|
Allison |
Lee |
|
|
|
Brianna |
Battle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 2840, Bipartisan Primary Care and Health Workforce Act
H.R. 3305 - Black Maternal Health Momnibus Act
H.R. 4420, the Preparedness and Response Reauthorization Act
H.R. 4531, the Support for Patients and Communities Reauthorization Act
H.R. 2534, PROTECT 340B Act of 2023
H.R. 5013, the Value in Health Care Act of 2023
H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program.
H.R. 7050 - Substance Use Disorder Workforce Act
S.4101/ H.R.7931 - the Preserving Emergency Access in Key Sites Act
Welcome Back to the Health Care Workforce Act
Issues related to essential hospital designation
Issues related to health equity
Issues related to the 340B Drug Pricing program
Issues related to contact pharmacies
Issues related to the health care workforce
Issues related to Community Paramedicine
Issues related to Artificial Intelligence and Health Care
Issues related to hospital digital infrastructure
Issues related to cybersecurity
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jason |
Pray |
|
|
|
Daniel |
Jones |
|
|
|
Allison |
Lee |
|
|
|
Brianna |
Battle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
HR 2872, Further Additional Continuing Appropriations and Other Extensions Act of 2024
H.R. 2872 - FY2024 Further Additional Cont. Approps. and Other Extensions Act
H.R. 7463 - FY2024 Extension of Continuing Appropriations and Other Matters Act
H.R. 4366 - Consolidated Appropriations Act, 2024
H.R. 2882 - Further Consolidated Appropriations Act, 2024
Issues related to funding for hospitals serving a safety net role
Issues related to essential hospital designation
Issues related to Critical Access Hospital designation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jason |
Pray |
|
|
|
Daniel |
Jones |
|
|
|
Allison |
Lee |
|
|
|
Brianna |
Battle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
H.R. 2584, the Safety from Violence for Healthcare Employees (SAVE) Act
S.2768 - SAVE Act.
17. House(s) of Congress and Federal agencies Check if None
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Beth |
Feldpush |
|
|
|
Jason |
Pray |
|
|
|
Daniel |
Jones |
|
|
|
Allison |
Lee |
|
|
|
Brianna |
Battle |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |